EPCAM− tumour cells were very resistant to chemotherapy-induced cell death in vivo as only 2% of EPCAM− tumour cells were caspase-3 positive compared with 9% of epithelial EPCAM+ tumour cells. This evidence concerns the gene CASP3 and neoplasm.